Is it safe to take propranolol together with vardenafil?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Is Propranolol Safe to Take with Vardenafil?

Yes, propranolol can generally be taken safely with vardenafil, but caution is warranted due to potential additive blood pressure lowering effects. There are no absolute contraindications to this combination, and it is commonly used in clinical practice for patients with both erectile dysfunction and cardiovascular conditions requiring beta-blockade.

Key Safety Considerations

Blood Pressure Effects

The primary concern with combining propranolol and vardenafil is additive hypotensive effects. Vardenafil causes transient decreases in blood pressure (mean maximum decrease of 7 mmHg systolic and 8 mmHg diastolic in healthy volunteers) 1. When combined with propranolol's antihypertensive effects, this could theoretically result in symptomatic hypotension, though this is rarely clinically significant in stable patients.

In a prospective trial of 354 hypertensive men with erectile dysfunction taking antihypertensive medications (average 1.5 medications per patient, including beta-blockers), vardenafil showed no significant changes in systolic or diastolic blood pressure or heart rate compared to placebo 2. This provides strong evidence that the combination is well-tolerated in real-world clinical scenarios.

Cardiovascular Risk Stratification

Before prescribing vardenafil to any patient on propranolol, assess cardiovascular risk:

  • Low-risk patients (controlled hypertension, mild stable angina, successful revascularization, uncomplicated past MI) can safely receive PDE5 inhibitors like vardenafil 3
  • High-risk patients (unstable angina, uncontrolled hypertension >170/110 mmHg, recent MI within 6 months, severe heart failure) should not receive vardenafil until cardiac condition stabilizes 1
  • Intermediate-risk patients require cardiology evaluation before treatment 3

Absolute Contraindication: Nitrates

The critical contraindication is concurrent nitrate use, NOT beta-blocker use 4, 1. Patients taking propranolol for angina who also require nitrates cannot use vardenafil. If a patient on vardenafil requires emergency nitrate therapy, wait at least 24 hours after vardenafil use (48 hours for tadalafil) 3, 4.

Practical Management

Dosing Recommendations

  • Start with vardenafil 5-10 mg as needed in patients on propranolol
  • Monitor for symptomatic hypotension, dizziness, or lightheadedness after initial doses
  • Patients should be counseled to avoid taking vardenafil if they feel hemodynamically unstable

Monitoring

  • Check baseline blood pressure before initiating vardenafil
  • Ensure propranolol dose is stable and well-tolerated
  • Advise patients to report dizziness, syncope, or excessive fatigue
  • Periodic follow-up to assess efficacy, side effects, and any changes in cardiovascular status or medications 3

Common Pitfalls to Avoid

  1. Do not confuse beta-blockers with nitrates: Beta-blockers are NOT contraindicated with PDE5 inhibitors; nitrates are absolutely contraindicated
  2. Do not withhold vardenafil unnecessarily: The evidence shows this combination is safe in appropriately selected patients 2
  3. Watch for drug-drug interactions affecting propranolol metabolism: Propranolol is metabolized by CYP2D6, CYP1A2, and CYP2C19 5. While vardenafil doesn't significantly affect these pathways 1, be aware of other medications that might increase propranolol levels and compound hypotensive effects
  4. Avoid in patients with left ventricular outflow obstruction: Both propranolol (negative inotrope) and vardenafil (vasodilator) can be problematic in aortic stenosis or hypertrophic cardiomyopathy 1

Evidence Quality

The safety data comes from high-quality guidelines 3, 4 and a well-designed prospective trial specifically examining vardenafil in hypertensive patients on multiple antihypertensives including beta-blockers 2. The FDA labeling for both drugs supports safe co-administration with appropriate monitoring 5, 1.

Bottom line: This combination is safe for most patients with stable cardiovascular disease on propranolol, provided nitrates are not being used and the patient is not in a high-risk cardiovascular category.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.